CEO Daniel Virnich highlighted a strong start to the year, reporting "revenue for Q1 increased by 10% versus the prior year period," mainly driven by robust performance in the retail Pharmacy and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback